Bone Fragility Disorders
Research activity includes osteogenesis imperfecta, with interest in therapies aimed at reducing fracture risk and supporting skeletal strength. The focus extends to treatment strategies involving parathyroid hormone analogues and bisphosphonates, as well as sequential approaches to bone protection.
- Osteogenesis imperfecta
- Fracture prevention
- Bone metabolism
- Bisphosphonate therapy
These interests reflect a clinical emphasis on inherited skeletal disease and interventions that target bone density and structural resilience.
Stroke and Cerebrovascular Injury
The sponsor also funds research in survivors of intracerebral haemorrhage, with attention to recovery after stroke and prevention of later cerebrovascular events. This area includes evaluation of antiplatelet therapy in the context of post-hemorrhagic brain injury.
- Intracerebral haemorrhage
- Stroke survivorship
- Antiplatelet therapy
- Major adverse cardiovascular or cerebrovascular events
Clinical interest is centered on balancing vascular protection with neurological safety in patients recovering from hemorrhagic stroke.
Cardiovascular and Cerebrovascular Risk Reduction
Trial activity includes outcomes related to major adverse cardiovascular or cerebrovascular events, highlighting interest in secondary prevention after brain hemorrhage. The research landscape spans both cardiovascular and cerebrovascular risk management in vulnerable patient groups.
- Secondary prevention
- Cerebrovascular risk
- Cardiovascular risk
- Post-stroke management
This field connects acute neurological disease with longer-term prevention of recurrent vascular complications.
Musculoskeletal Therapeutics
Work in this area supports investigation of treatments that influence bone remodelling and skeletal integrity. The sponsor’s portfolio includes interest in agents used for strengthening bone tissue and reducing the burden of recurrent injury in chronic bone disease.
- Bone remodelling
- Skeletal integrity
- Bone-strengthening therapy
- Chronic bone disease
These topics place emphasis on long-term management of disorders where bone fragility is a central clinical concern.
